Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 01 Jul 2025 for MetaVia Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Andrew I. Koven: trading record in brief
Andrew I. Koven is a declared insider at 3 companies (board member); the most frequent names are KALA BIO, Inc., MetaVia Inc. and Aralez Pharmaceuticals Inc. The record holds 9 filings, for trades running from 5 February 2016 to 30 June 2025.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 1 July 2025: a share grant, in MetaVia Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Andrew I. Koven
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
28,147 shares0Common StockSEC:0001104659-25-064706:0
3,050 shares0Common StockSEC:0001415889-25-017611:0
1,750 shares0Common StockSEC:0001415889-24-016570:0
5,051 shares0Common StockSEC:0001104659-24-069786:0
87,500 shares0Common StockSEC:0001104659-23-084992:0
7,515 shares0Common StockSEC:0001415889-23-010288:0
2,197 sharesCommon StockSEC:0001415889-23-009140:0
25,000 shares0Common StockSEC:0001415889-21-003121:0
1,476,674 sharesCommon SharesSEC:0001104659-16-095183:0
9 of 9 declarations
